Mesa Laboratories is a scientific & technical instruments business based in the US. Mesa Laboratories shares (MLAB) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $103.05 – a decrease of 8.32% over the previous week. Mesa Laboratories employs 736 staff and has a trailing 12-month revenue of around $228.4 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $103.05 |
|---|---|
| 52-week range | $83.58 - $141.00 |
| 50-day moving average | $123.21 |
| 200-day moving average | $111.57 |
| Wall St. target price | $140.00 |
| PE ratio | N/A |
| Dividend yield | $0.64 (0.62%) |
| Earnings per share (TTM) | $-45.62 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $102.435 from 2024-11-15
| 1 week (2024-11-11) | -13.88% |
|---|---|
| 1 month (2024-10-18) | -24.63% |
| 3 months (2024-08-16) | -20.90% |
| 6 months (2024-05-17) | -16.19% |
| 1 year (2023-11-17) | 13.91% |
|---|---|
| 2 years (2022-11-18) | -42.00% |
| 3 years (2021-11-18) | 304.5151 |
| 5 years (2019-11-18) | 227.893 |
Valuing Mesa Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Mesa Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Mesa Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $41.6 million.
The EBITDA is a measure of a Mesa Laboratories's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $228.4 million |
|---|---|
| Operating margin TTM | 6.85% |
| Gross profit TTM | $116.6 million |
| Return on assets TTM | 1.69% |
| Return on equity TTM | -89.46% |
| Profit margin | -107.56% |
| Book value | $29.79 |
| Market Capitalization | $556.4 million |
TTM: trailing 12 months
Dividend payout ratio: 11.51% of net profits
Recently Mesa Laboratories has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Mesa Laboratories shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Mesa Laboratories's case, that would currently equate to about $0.64 per share.
While Mesa Laboratories's payout ratio might seem low, this can signify that Mesa Laboratories is investing more in its future growth.
Mesa Laboratories's most recent dividend payout was on 15 December 2024. The latest dividend was paid out to all shareholders who bought their shares by 28 November 2024 (the "ex-dividend date").
Over the last 12 months, Mesa Laboratories's shares have ranged in value from as little as $83.5802 up to $141.0017. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Mesa Laboratories's is 0.865. This would suggest that Mesa Laboratories's shares are less volatile than average (for this exchange).
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.